Is BCRX stock a Buy, Sell, or Hold?

Based on our analysis, BCRX is currently a HOLD with moderate confidence. 📊 HOLD: BCRX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of BCRX stock?

Our analysis estimates the fair value range for BCRX to be between $6.44 and $8.00. The current price is $8.50.

What is the analyst price target for BCRX?

The average Wall Street analyst price target for BCRX is $21.20. This implies a potential upside of 147.4% from current levels.

BCRX Stock Analysis: Buy, Sell, or Hold?

BCRX - BioCryst Pharmaceuticals Inc

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

$8.50

-0.07 (-0.82%) ▼

5d: +7.59%

30d: +26.87%

90d: +18.72%

HOLD

MODERATE Confidence

Protect Your BCRX Gains

Analysis Updated: Mar 5, 2026 12:00 AM ET

Earnings: Feb 26, 2026 0d

Smart Money Accumulation

BCRX is down 3.4% this week, but smart money is accumulating calls. Top strike: $8 2026-03-20 with 5,364 OI. Call ratio: 98% View Scanner →

Strength: 6.5/10

Get Alerted When BCRX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: BCRX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: -12.2%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$6.98

Based on -4.1% avg growth

INTRINSIC VALUE TODAY

$4.34

Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.2x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: BCRX is currently trading at $8.50, which is considered extended relative to its 30-day fair value range of $6.44 to $8.00. The stock's valuation (Forward PE: 19.9) is in line with its historical norms (20.2). Remarkably, the market is currently pricing in an annual earnings decline of 0.4% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, BCRX is showing sideways momentum. Immediate support is located at $7.31, while resistance sits at $8.86.

Market Sentiment: BCRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $21.20 (+147.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED

Fair Price Range $6.44 - $8.00

Company Quality Score 56/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 57.1%

Protect Your Profits

BCRX is technically overbought (RSI 71). Consider hedging now to protect against a potential pullback while keeping your upside.

View Profit Protection Plan

All Signals

BEARISH: Price extended above range (+6.2% above fair value)
BULLISH: Strong technical setup (60/100)
BULLISH: High volume confirmation
BULLISH: Trading 147.4% below Wall St target ($21.20)

Fair Price Analysis

30-Day Fair Range $6.44 - $8.00

Current vs Fair Value EXTENDED

Support & Resistance Levels

Support Level $7.31

Resistance Level $8.86

Current Trend Sideways

Technical data as of Mar 5, 2026

Fundamental Context

Forward P/E (Next Year Est.) 19.93

Wall Street Target $21.20 (+147.4%)

Revenue Growth (YoY) 36.1%

Profit Margin -1.5%

Valuation Discount vs History -0.4% cheaper

PE vs Historical 19.9 vs 20.2 FAIR

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -0.4% (market-implied from PE analysis)

1-Year Target $8.54 (0%)

2-Year Target $8.50 (-1%)

3-Year Target $8.47 (-1%)

3-Yr Target (if PE normalizes) (PE: 20→20) $8.58 (+0%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 22.6, Growth: -12.2%) $7.08 (+-17%)

Base: (SPY PE: 19.9, Growth: -12.2%) $6.25 (-27%)

Bear: (PE: 16.9, Growth: -12.2%) $5.31 (-38%)

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 19.9 to 20.2

Stabilization Target: $8.69 (+1.4%)

PE Expansion Potential: +1.4%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: March 06, 2026 5:36 AM ET
Data refreshes hourly during market hours. Next update: 6:36 AM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is BCRX showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

Alane P Barnes SELL 21773 shares 2025-12-22

Alane P Barnes SELL 19770 shares 2025-12-03

Alane P Barnes SELL 50906 shares 2025-12-02

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for BCRX.

Create Free Account

Already have an account? Log In

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
NBIX Neurocrine Biosciences I…	STRONG BUY 25 analysts	$177	59 HOLD
ZTS Zoetis Inc	STRONG BUY 19 analysts	$154	58 HOLD
LNTH Lantheus Holdings Inc	STRONG BUY 13 analysts	$85	67 BUY
TEVA Teva Pharma Industries L…	STRONG BUY 11 analysts	$38	58 HOLD
AVDL Avadel Pharmaceuticals P…	STRONG BUY 8 analysts	$21	62 BUY

NBIX Neurocrine Biosci…

59 HOLD

ZTS Zoetis Inc

58 HOLD

LNTH Lantheus Holdings…

67 BUY

TEVA Teva Pharma Indus…

58 HOLD

AVDL Avadel Pharmaceut…

62 BUY

Advanced BCRX Option Strategies

Professional options setups generated by AI based on today's BCRX price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for BCRX

BCRX Technical Chart BCRX Price Prediction BCRX Earnings Date BCRX Investment Advisor BCRX Fair Price Analyzer BCRX Options Advisor BCRX Options Chain BCRX Options Analysis BCRX Competitors

Compare BCRX with Other Stocks

BCRX vs CCL
Winner: CCL

BCRX vs UPS

BCRX vs TLT

AVAV vs BCRX

Create New Comparison

Tradestie